Cochlear: Interim result 2013

Even after recent falls, investors are pricing in a return to the glory days for Cochlear, but its interim result suggests potential customers may be more wary.

They say it can take years to build a reputation and seconds to break it, and so it seemed with Cochlear in September 2011, when the company announced the recall of its Nucleus CI500 range and saw its share price tumble 40% to a low of $45.75.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles